Bifogade filer
Kurs & Likviditet
Kalender
2025-04-24 | Årsstämma 2025 |
2025-02-14 | Bokslutskommuniké 2024 |
2024-11-06 | Kvartalsrapport 2024-Q3 |
2024-08-23 | Kvartalsrapport 2024-Q2 |
2024-05-14 | Kvartalsrapport 2024-Q1 |
2024-04-26 | X-dag ordinarie utdelning CI 0.00 SEK |
2024-04-25 | Årsstämma 2024 |
2024-02-16 | Bokslutskommuniké 2023 |
2023-11-03 | Kvartalsrapport 2023-Q3 |
2023-11-03 | Extra Bolagsstämma 2023 |
2023-08-24 | Kvartalsrapport 2023-Q2 |
2023-05-10 | Kvartalsrapport 2023-Q1 |
2023-04-21 | X-dag ordinarie utdelning CI 0.00 SEK |
2023-04-20 | Årsstämma 2023 |
2023-02-17 | Bokslutskommuniké 2022 |
2022-11-04 | Kvartalsrapport 2022-Q3 |
2022-08-25 | Kvartalsrapport 2022-Q2 |
2022-05-06 | Kvartalsrapport 2022-Q1 |
2022-04-22 | X-dag ordinarie utdelning CI 0.00 SEK |
2022-04-21 | Årsstämma 2022 |
2022-02-18 | Bokslutskommuniké 2021 |
2021-10-22 | Kvartalsrapport 2021-Q3 |
2021-08-25 | Kvartalsrapport 2021-Q2 |
2021-08-09 | Extra Bolagsstämma 2021 |
2021-05-07 | Kvartalsrapport 2021-Q1 |
2021-05-03 | X-dag ordinarie utdelning CI 0.00 SEK |
2021-04-22 | Årsstämma 2021 |
2021-02-19 | Bokslutskommuniké 2020 |
2020-11-05 | Kvartalsrapport 2020-Q3 |
2020-08-06 | Kvartalsrapport 2020-Q2 |
2020-05-07 | Kvartalsrapport 2020-Q1 |
2020-04-17 | X-dag ordinarie utdelning CI 0.00 SEK |
2020-04-16 | Årsstämma 2020 |
2020-02-14 | Bokslutskommuniké 2019 |
2019-11-05 | Kvartalsrapport 2019-Q3 |
2019-08-06 | Kvartalsrapport 2019-Q2 |
2019-04-23 | Kvartalsrapport 2019-Q1 |
2019-04-12 | X-dag ordinarie utdelning CI 0.00 SEK |
2019-04-11 | Årsstämma 2019 |
2019-02-12 | Bokslutskommuniké 2018 |
2018-11-06 | Kvartalsrapport 2018-Q3 |
2018-08-03 | Kvartalsrapport 2018-Q2 |
2018-05-04 | Kvartalsrapport 2018-Q1 |
2018-04-13 | X-dag ordinarie utdelning CI 0.00 SEK |
2018-04-12 | Årsstämma 2018 |
2018-02-02 | Bokslutskommuniké 2017 |
2017-10-27 | Kvartalsrapport 2017-Q3 |
2017-07-21 | Kvartalsrapport 2017-Q2 |
2017-05-12 | X-dag ordinarie utdelning CI 0.00 SEK |
2017-05-11 | Årsstämma 2017 |
2017-04-28 | Kvartalsrapport 2017-Q1 |
2017-01-27 | Bokslutskommuniké 2016 |
2016-10-21 | Kvartalsrapport 2016-Q3 |
2016-07-15 | Kvartalsrapport 2016-Q2 |
2016-05-13 | X-dag ordinarie utdelning CI 0.00 SEK |
2016-05-12 | Årsstämma 2016 |
2016-04-22 | Kvartalsrapport 2016-Q1 |
2016-01-29 | Bokslutskommuniké 2015 |
2015-10-23 | Kvartalsrapport 2015-Q3 |
2015-07-17 | Kvartalsrapport 2015-Q2 |
2015-05-08 | X-dag ordinarie utdelning CI 0.00 SEK |
2015-05-07 | Årsstämma 2015 |
2015-04-24 | Kvartalsrapport 2015-Q1 |
2015-01-30 | Bokslutskommuniké 2014 |
2014-10-24 | Kvartalsrapport 2014-Q3 |
2014-07-18 | Kvartalsrapport 2014-Q2 |
2014-05-16 | X-dag ordinarie utdelning CI 0.00 SEK |
2014-05-15 | Årsstämma 2014 |
2014-04-24 | Kvartalsrapport 2014-Q1 |
2014-01-31 | Bokslutskommuniké 2013 |
2013-10-18 | Extra Bolagsstämma 2013 |
2013-10-11 | Kvartalsrapport 2013-Q3 |
2013-07-19 | Kvartalsrapport 2013-Q2 |
2013-04-25 | X-dag ordinarie utdelning CI 0.00 SEK |
2013-04-24 | Årsstämma 2013 |
2013-04-19 | Kvartalsrapport 2013-Q1 |
2013-01-22 | Bokslutskommuniké 2012 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Energi & Miljö |
Industri | Energikällor |
In December 2023, Cell Impact AB (publ) (Nasdaq First North Growth Market: CI) ("Cell Impact" or the "Company") carried out a rights issue of Units (the "Rights Issue"). The first day of trading in warrants of series 2023/2024 TO2 (the "Warrants") issued as part of the Rights Issue on Nasdaq First North Growth Market is tomorrow, 19 December 2023. The last day of trading in the Warrants is 25 September 2024. The Warrants will be traded under the short name (ticker) CI TO2.
Through the Rights Issue, 128,905,776 Warrants have been issued.
Each Warrant entitles the holder to subscribe for one (1) new share in the Company during the period 16 September 2024 up to and including 30 September 2024. The subscription price for subscription of shares by exercise of Warrants corresponds to 70 percent of the volume-weighted average price of the Company's share on Nasdaq First North Growth Market during the period 2 September 2024 up to and including 13 September 2024. However, the subscription price can at a minimum amount to SEK 0.12 and at a maximum amount to SEK 0.44 per share.
Advisers
In conjunction with the Rights Issue, the Company has engaged Carnegie Investment Bank AB (publ) as Sole Global Coordinator and Joint Bookrunner and Pareto Securities AB as Joint Bookrunner. Advokatfirman Vinge acts as legal adviser to the Company and Baker McKenzie represents Sole Clobal Coordinator and Joint Bookrunners in connection with the Rights Issue.
Pär Teike
CEO and IR contact, Cell Impact AB (publ)
+46 73-024 06 84 or paer.teike@cellimpact.com